Tag: Biomed
Ulisse Biomed, new guidance: positive EBITDA from 2026
(Finance) – Ulysses Biomeda healthcare biotech company listed on Euronext Growth Milan, expects that i revenues 2024including grants, are equal to approximately 950 thousand eurosderiving mainly from the sales of…
Ulisse BioMed, ValueTrack lowers fair value
(Finance) – ValueTrack lowered to 1.25 euros per share (from the previous 1.90 euros) the fair value on the title Ulysses Biomedhealthcare biotech company listed on Euronext Growth Milan, including…
Ulisse BioMed, ValueTrack lowers target price and estimates
(Finance) – ValueTrack has decreased fair value and estimates on Ulysses Biomed, healthcare biotech company listed on Euronext Growth Milan. In particular, the fair value was reduced to € 1.65…
Ulisse Biomed, Laura Amadesi joins the Board of Directors as an independent
(Finance) – The Board of Directors of Ulysses Biomedhealthcare biotech company listed on Euronext Growth Milan, has co-opted as independent director Laura Amadesi to replace Filippo Rizziwho resigned for personal…